Clinical PET/MR Imaging in Dementia and Neuro-Oncology
Research output: Contribution to journal › Review › Research › peer-review
The introduction of hybrid PET/MRI systems allows simultaneous multimodality image acquisition of high technical quality. This technique is well suited for the brain, and particularly in dementia and neuro-oncology. In routine use combinations of well-established MRI sequences and PET tracers provide the most optimal and clinically valuable protocols. For dementia the [18F]-fluorodeoxyglucose (FDG) has merit with a simultaneous four sequence MRI protocol of 20 min supported by supplementary statistical reading tools and quantitative measurements of the hippocampal volume. Clinical PET/MRI using [18F]-fluoro-ethyl-tyrosine (FET) also abide to the expectations of the adaptive and versatile diagnostic tool necessary in neuro-oncology covering both simple 20 min protocols for routine treatment surveillance and complicated 90 min brain and spinal cord protocols in pediatric neuro-oncology under general anesthesia. The clinical value of adding advanced MRI sequences in multiparametric imaging setting, however, is still undocumented.
Original language | English |
---|---|
Journal | PET Clinics |
Volume | 11 |
Issue number | 4 |
Pages (from-to) | 441-52 |
Number of pages | 12 |
ISSN | 1556-8598 |
DOIs | |
Publication status | Published - Oct 2016 |
- Brain, Brain Mapping, Brain Neoplasms, Dementia, Humans, Magnetic Resonance Imaging, Multimodal Imaging, Positron-Emission Tomography, Journal Article, Review
Research areas
ID: 179311788